GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Net Interest Income

The Searle Co (KAR:SEARL) Net Interest Income : ₨-2,691 Mil (TTM As of Mar. 2025)


View and export this data going back to 1993. Start your Free Trial

What is The Searle Co Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. The Searle Co's net interest income for the three months ended in Mar. 2025 was ₨-362 Mil. Its net interest income for the trailing twelve months (TTM) ended in Mar. 2025 was ₨-2,691 Mil.

The Searle Co Net Interest Income Historical Data

The historical data trend for The Searle Co's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

The Searle Co Net Interest Income Chart

The Searle Co Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Net Interest Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -639.81 -1,431.02 -2,104.08 -3,235.87 -3,611.33

The Searle Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -874.05 -931.86 -749.72 -646.88 -362.45

The Searle Co Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨-2,691 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Searle Co Net Interest Income Related Terms

Thank you for viewing the detailed overview of The Searle Co's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

The Searle Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » The Searle Co Ltd (KAR:SEARL) » Definitions » Net Interest Income
Comparable Companies
KAR:AGPL KAR:CPHL KAR:MACTER KAR:FEROZ KAR:ABOT KAR:GLAXO ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538
Traded in Other Exchanges
N/A
Address
Tipu Sultan Road, Plot No. 1, One IBL Centre, 2nd Floor, Block 7 and 8, D.M.C.H.S, Off Shahra-e-Faisal, Karachi, SD, PAK, 75530
Website
https://www.searlecompany.com
The Searle Co Ltd is a pharmaceutical company. It is principally engaged in the manufacture of pharmaceutical and other consumer products. The company manufactures pharmaceutical products like Hydryllin, Extor, Nuberol, Forte, Peditral, Selanz SR, Tramal, and other products. Its pharmaceutical product range covers the therapeutic areas of cardiovascular, antibiotics, nutrition, respiratory care, gastroenterology, oncology, hepatology, neurology and psychiatry, probiotics, antibiotics, and nutritional care.

The Searle Co Headlines

No Headlines